A carregar...
Addition of the C‐terminus of CD6 to a chimeric antigen receptor enhances cytotoxicity and does not compromise expression
T cells expressing chimeric antigen receptors (CARs) are a promising new cancer immunotherapy that has now reached the clinic. CARs are synthetic receptors that redirect T cells towards a tumour‐associated antigen and activate them through various fused signalling regions, for example derived from C...
Na minha lista:
| Publicado no: | Immunology |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6328988/ https://ncbi.nlm.nih.gov/pubmed/30300924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.13009 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|